MedPharm
Private Company
Funding information not available
Overview
MedPharm is a long-established, privately-held CDMO that has carved out a strong niche in the topical and transdermal drug delivery sector. The company offers a fully integrated suite of services, including formulation development, analytical and bioanalytical testing, specialized in-vitro permeation models, and GMP clinical and commercial manufacturing. With deep scientific expertise and a focus on regulatory compliance, MedPharm serves pharmaceutical clients globally, supporting generics, OTC, and prescription products from concept to market. Its business model is entirely service-based, generating revenue from client projects across the development lifecycle.
Technology Platform
Specialized in-vitro testing platforms for topical/transdermal products, including High Throughput Skin Permeation Testing, In Vitro Permeation Testing (IVPT), In Vitro Release Testing (IVRT), Reconstructed Human Epithelium (RHE) models, and Nail Permeation testing.
Opportunities
Risk Factors
Competitive Landscape
MedPharm competes in a niche segment against other specialized dermatology CDMOs and the topical/transdermal divisions of large, global CDMOs. Its competitive advantage is its deep, focused expertise and end-to-end integrated service model for a specific dosage form.